Evidence map›Paper›PMID 24747335›Full record

ReviewBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2014

Sleep disruption in hematopoietic cell transplantation recipients: prevalence, severity, and clinical management.

Heather S L Jim, Bryan Evans, Jiyeon M Jeong, Brian D Gonzalez, Laura Johnston, Ashley M Nelson, Shelli Kesler, Kristin M Phillips, Anna Barata, Joseph Pidala and 1 more

Abstract readReview
In one paragraph

Review in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Trial
  2. Relationship between circadian activity rhythms and fatigue in hospitalized children with CNS cancers receiving high-dose chemotherapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Heather S L JimMoffitt Cancer Center, Tampa, Florida. Electronic address: heather.jim@moffitt.org.
Bryan EvansDepartment of Psychology, University of South Florida, Tampa, Florida.
Jiyeon M JeongDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
Brian D GonzalezMoffitt Cancer Center, Tampa, Florida.
Laura JohnstonDivision of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, California.
Ashley M NelsonDepartment of Psychology, University of South Florida, Tampa, Florida.
Shelli KeslerDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
Kristin M PhillipsMoffitt Cancer Center, Tampa, Florida.
Anna BarataMoffitt Cancer Center, Tampa, Florida; Psychiatry and Legal Medicine PhD Program, Universitat Autònoma de Barcelona, Barcelona, Spain.
Joseph PidalaDepartment of Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, Florida.
Oxana PaleshDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.

Funding

Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors (ProbC2)R01CA172145 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI KESLER, SHELLI R, PALESH, OXANA G · 2012 to 2024
$3.3M
Brief Behavioral Intervention for Insomnia During ChemotherapyR01CA181659 · NCI · STANFORD UNIVERSITY · PI PALESH, OXANA G · 2014 to 2018
$3.1M
Genetic Predictors of Cognitive Function, Depression and Fatigue in CancerK07CA138499 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI JIM, HEATHER S.L. · 2009 to 2013
$713k
Management of Insomnia in Cancer PatientsK07CA132916 · NCI · UNIVERSITY OF ROCHESTER · PI PALESH, OXANA G · 2008 to 2012
$679k
RCT for Mechanisms and Management of Sleep Utilizing Multicenter Clinical Oncology NetworkR21CA185678 · NCI · STANFORD UNIVERSITY · PI MUSTIAN, KAREN M., PALESH, OXANA G · 2015 to 2016
$381k
NCI NIH HHS K07 CA132916NCI NIH HHS K07 CA138499NCI NIH HHS R01 CA172145NCI NIH HHS R01 CA181659NCI NIH HHS R21 CA185678
6 · The paper itself

Abstract

Sleep disruption is common among hematopoietic cell transplant (HCT) recipients, with over 50% of recipients experiencing sleep disruption pre-transplant, with up to 82% of patients experiencing moderate to severe sleep disruption during hospitalization for transplant and up to 43% after transplant. These rates of sleep disruption are substantially higher than what we see in the general population. Although sleep disruption can be distressing to patients and contribute to diminished quality of life, it is rarely discussed during clinical visits. The goal of the current review is to draw attention to sleep disruption and disorders (ie, insomnia, obstructive sleep apnea, restless legs syndrome) as a clinical problem in HCT in order to facilitate patient education, intervention, and research. We identified 35 observational studies published in the past decade that examined sleep disruption or disorders in HCT. Most studies utilized a single item measure of sleep, had small sample size, and included heterogeneous samples of patients. Six studies of the effects of psychosocial and exercise interventions on sleep in HCT have reported no significant improvements. These results highlight the need for rigorous observational and interventional studies of sleep disruption and disorders in HCT recipients..

Indexed as

Hematopoietic Stem Cell TransplantationCross-Sectional StudiesHematologic NeoplasmsHospitalizationHumansPhysical Therapy ModalitiesPsychotherapyQuality of LifeRestless Legs SyndromeRisk FactorsSeverity of Illness IndexSleep Apnea, ObstructiveSleep Initiation and Maintenance DisordersSurveys and QuestionnairesTransplantation, HomologousHematopoietic cell transplantManagement of sleep disruptionSleep disruption

Identifiers

PMID24747335
PMCPMC4163090

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.